Abstract
This study was aimed at investigating the anti-inflammatory and anticholinesterase activity of six naturally occurring flavonoids: (−) pinostrobin (1), 2′,4′-dihydroxy-3′,6′-dimethoxychalcone (2), 6-8-diprenyleriodictyol (3), isobavachalcone (4), 4-hydroxylonchocarpin (5) and 6-prenylapigenin (6). These compounds were isolated from Dorstenia and Polygonum species used traditionally to treat pain. The anti-inflammatory activity was determined by using the Griess assay and the 15-lipoxygenase inhibitory activity was determined with the ferrous oxidation-xylenol orange assay. Acetylcholinesterase inhibition was determined by the Ellman’s method. At the lowest concentration tested (3.12 µg/ml), compounds 2, 3 and 4 had significant NO inhibitory activity with 90.71, 84.65 and 79.57 % inhibition respectively compared to the positive control quercetin (67.93 %). At this concentration there was no significant cytotoxicity against macrophages with 91.67, 72.86 and 70.86 % cell viability respectively, compared to 73.1 % for quercetin. Compound 4 had the most potent lipoxygenase inhibitory activity (IC50 of 25.92 µg/ml). With the exception of (−) pinostrobin (1), all the flavonoids had selective anticholinesterase activity with IC50 values ranging between 5.93 and 8.76 µg/ml compared to the IC50 4.94 µg/ml of eserine the positive control. These results indicate that the studied flavonoids especially isobavachalcone are potential anti-inflammatory natural products that may have the potential to be developed as therapeutic agents against inflammatory conditions and even Alzheimer’s disease.
Similar content being viewed by others
References
Adjanohoun, J.E., N. Aboubakar, K. Dramane, M.E. Ebot, J.A. Ekpere, E.G. Enow-Orock, D. Focho, Z.E. Gbile, A. Kamanyi, K.J. Kamsu, A. Keita, T. Mbenkum, C.N. Mbi, A.L. Mbiele, I.L. Mbome, N.K. Miburu, W.L. Nancy, B. Nkongmeneck, B. Satabie, A. Sofowora, V. Tamze, and C.K. Wirmum. 1996. Traditional medicine and pharmacopoeia: contribution to ethnopharmacological and floristic studies in Cameroon. Lagos: OUA/ST&RC.
Akiyama, H., S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S.T. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O’Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk, and T. Wyss-Coray. 2000. Inflammation and Alzheimer’s disease. Neurobiology of Aging 21: 383–421.
Ayaz, M., M. Junaid, J. Ahmed, F. Ullah, A. Sadiq, S. Ahmad, and M. Imran. 2014. Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complementary and Alternative Medicine 14: 145.
Bakthir, H., N.A.A. Ali, N. Arnoldc, A. Teichertc, and L. Wessjohannc. 2011. Anticholinesterase activity of endemic plant extracts from Soqotra. African Journal of Traditional, Complementary and Alternative Medicines 8: 296–299.
Black, S., C.C. Brideau, M. Cirino, M. Belley, J. Bosquet, C.C. Chan, and I.W. Rodger. 1998. Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs. Journal of Cardiovascular Pharmacology 32: 686–694.
Bouquet, A. 1969. Feticheurs et medecines traditionnelles du Congo Brazaville. Memoires ORSTOM 366: 295.
Brain, S.D., and T.J. Williams. 1990. Leukotrienes and inflammation. Pharmacology & Therapeutic 46: 57–66.
Chen, Y.-C., S.-C. Shen, W.-R. Lee, W.-C. Hou, L.-L. Yang, and T.J.F. Lee. 2001. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. Journal of Cellular Biochemistry 82: 537–548.
del Carmen Pinto, M., A. Tejeda, A.L. Duque, and P. Macias. 2007. Determination of lipoxygenase activity in plant extracts using a modified ferrous oxidation-xylenol orange assay. Journal of Agricultural and Food Chemistry 55: 5956–5959.
Di Carlo, G., N. Mascolo, A.A. Izzo, and F. Capasso. 1999. Flavonoids: Old and new aspects of a class of natural therapeutic drugs. Life Sciences 65: 337–353.
Dzoyem, J.P., A.H.L. Nkuete, V. Kuete, M.F. Tala, H.K. Wabo, S.K. Guru, V.S. Rajput, S. Akash, P. Tane, I.A. Khan, A.K. Saxena, H. Laatsch, and N.H. Tan. 2012. Cytotoxicity and antimicrobial activity of the methanol extract and compounds from Polygonum limbatum. Planta Medica 78: 787–792.
Ellman, G.L., K.D. Courtney, V. Andres Jr, and R.M. Featherstone Jr. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7: 88–95.
Guzik, T.J., R. Korbut, and T. Adamek-Guzik. 2003. Nitric oxide and superoxide in inflammation and immune regulation. Journal of Physiology and Pharmacology 54: 469–487.
Ji, H.F., and H.-Y. Zhang. 2006. Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer’s disease. Journal of Molecular Structure: THEOCHEM 767: 3–9.
Kim, Y.H., J. Kim, H. Park, and H.P. Kim. 2007. Anti-inflammatory activity of the synthetic chalcone derivatives: Inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells. Biological and Pharmaceutical Bulletin 30: 1450–1455.
Kumar, S., and A.K. Pandey. 2013. Chemistry and biological activities of flavonoids: An overview. The Scientific World Journal 2013: 162750.
Mazid, M.A., B.K. Datta, S.C. Bachar, S.A.M.K. Bashar, L. Nahar, and S.D. Sarker. 2010. Analgesic and anti-inflammatory activities of Polygonum stagninum. Pharmaceutical Biology 48: 770–774.
Min, H.-Y., S.Y. Song, B. Lee, S. Kim, and S.K. Lee. 2010. Inhibition of lipopolysaccharide-induced nitric oxide production by antofine and its analogues in RAW 264.7 macrophage cells. Chemistry & Biodiversity 7: 409–414.
Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65: 55–63.
Mu, M.M., D. Chakravortty, T. Sugiyama, N. Koide, K. Takahashi, I. Mori, T. Yoshida, and T. Yokochi. 2001. The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. Journal of Endotoxin Research 7: 431–438.
Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB Journal 6: 3051–3064.
Ngadjui, B.T., S.F. Kouam, E. Dongo, G.W.F. Kapche, and B.M. Abegaz. 2000. Prenylated flavonoids from the aerial parts of Dorstenia mannii. Phytochemistry 55: 915–919.
Ngadjui, B.T., E. Dongo, B.M. Abegaz, S. Fotso, and H. Tamboue. 2002. Dinklagins A, B and C: three prenylated flavonoids and other constituents from the twigs of Dorstenia dinklagei. Phytochemistry 61: 99–104.
Ngameni, B., M. Touaibia, A. Belkaid, P. Ambassa, J. Watchueng, R. Patnam, B.T. Ngadjui, B. Annabi, and R. Roy. 2007. Inhibition of matrix metalloproteinase-2 secretion by chalcones from the twigs of Dorstenia barteri Bureau. Arkivoc 2007: 91–103.
Omisore, N.O.A., C.O. Adewunmi, E.O. Iwalewa, B.T. Ngadjui, J. Watchueng, B.M. Abegaz, and J.A.O. Ojewole. 2004. Antinociceptive and anti-inflammatory effects of Dorstenia barteri (Moraceae) leaf and twig extracts in mice. Journal of Ethnopharmacology 95: 7–12.
Ramassamy, C. 2006. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets. European Journal of Pharmacology 545: 51–64.
Sadik, C.D., H. Sies, and T. Schewe. 2003. Inhibition of 15-lipoxygenases by flavonoids: Structure–activity relations and mode of action. Biochemical Pharmacology 65: 773–781.
Shin, H.J., D.H. Shon, and H.S. Youn. 2013. Isobavachalcone suppresses expression of inducible nitric oxide synthase induced by toll-like receptor agonists. International Immunopharmacology 15: 38–41.
Tabet, N. 2006. Acetylcholinesterase inhibitors for Alzheimer’s disease: Anti-inflammatories in acetylcholine clothing! Age and Ageing 35: 336–338.
Acknowledgments
The University of Pretoria provided a postdoctoral fellowship to JPD. The National Research Foundation (NRF) and Medical Research Council (MRC) provided funding to support this study.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Dzoyem, J.P., Nkuete, A.H.L., Ngameni, B. et al. Anti-inflammatory and anticholinesterase activity of six flavonoids isolated from Polygonum and Dorstenia species. Arch. Pharm. Res. 40, 1129–1134 (2017). https://doi.org/10.1007/s12272-015-0612-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-015-0612-9